Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7572895 Transferrin receptor antibodies

Patent 7572895 was granted and assigned to Raven Biotechnologies on August, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Raven Biotechnologies

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jennie P. Mather0

Penelope E. Roberts0

Ronghao Li0

Date of Patent

August 11, 2009

0

Patent Application Number

111479420

Date Filed

June 7, 2005

0

Patent Citations Received

US Patent 11942149 Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof

0

US Patent 11685781 Variant CD3-binding domains and their use in combination therapies for the treatment of disease

0

US Patent 11697684 Tri-specific binding molecules that specifically bind to multiple cancer antigens

0

US Patent 11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4

0

Patent Primary Examiner

Karen A. Canella

0

Patent abstract

The invention provides further characterization of the disease and cancer-associated antigen, transferrin receptor. The invention also provides a novel family of antibodies that bind to the transferrin receptor, methods of diagnosing and treating various human cancers and diseases that express transferrin receptor.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7572895 Transferrin receptor antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool